diabetes meds Flashcards
(27 cards)
give type/mechanism: lispro
insulin, rapid acting
give type/mechanism: aspart
insulin, rapid acting
give type/mechanism: glulisine
insulin, rapid acting
give type/mechanism: “regular” insulin
insulin, short acting
give type/mechanism: NPH
insulin, intermediate acting
give type/mechanism: glargine
insulin, long acting
give type/mechanism: detemir
insulin, long acting
give type/mechanism: metformin
biguanide, reduces hepatic glucose output
decreases gluconeogenesis
increases glycolysis
increases peripheral glucose uptake (insulin sensitivity)
give type/mechanism: tolbutamide
1st gen sulfonylurea
close K+ channel in beta cell so cell depolarizes triggering insulin release via Ca2+ influx
give type/mechanism: chlorpropamide
1st gen sulfonylurea
close K+ channel in beta cell so cell depolarizes triggering insulin release via Ca2+ influx
give type/mechanism: glyburide
2nd gen sulfonylurea
close K+ channel in beta cell so cell depolarizes triggering insulin release via Ca2+ influx
give type/mechanism: glimepiride
2nd gen sulfonylurea
close K+ channel in beta cell so cell depolarizes triggering insulin release via Ca2+ influx
give type/mechanism: glipizide
2nd gen sulfonylurea
close K+ channel in beta cell so cell depolarizes triggering insulin release via Ca2+ influx
give type/mechanism: pioglitazone
glitazone/thiazolidinediones
binds to PPAR-gamma nuclear transcription regulator –> increases insulin sensitivity in peripheral tissue
give type/mechanism: rosiglitazone
glitazone/thiazolidinediones
binds to PPAR-gamma nuclear transcription regulator –> increases insulin sensitivity in peripheral tissue
give type/mechanism: acarbose
alpha-glucosidase inhibitor
inhibits intestinal brush border alpha glucosidases. delayed sugar hydrolysis and glucose absorption –> decreased postprandial hyperglycemia
give type/mechanism: miglitol
alpha-glucosidase inhibitor
inhibits intestinal brush border alpha glucosidases. delayed sugar hydrolysis and glucose absorption –> decreased postprandial hyperglycemia
give type/mechanism: pramlintide
amylin analog
decreases gastic emptying
decreases glucagon
(amylin is cosecreted with insulin from the pancreatic β-cells and acts centrally to slow gastric emptying, suppress postprandial glucagon secretion, and decrease food intake)
give type/mechanism: exenatide
GLP-1 analog
increase insulin
decrease glucagon release
(GLP-1 is secreted by intestinal L cells in response to food intake and stimulates proinsulin gene transcription and glucose dependent insulin secretion, slows gastric emptying, promotes satiety, reduces food intake, inhibits glucagon secretion)
give type/mechanism: liraglutide
GLP-1 analog
increase insulin
decrease glucagon release
(GLP-1 is secreted by intestinal L cells in response to food intake and stimulates proinsulin gene transcription and glucose dependent insulin secretion, slows gastric emptying, promotes satiety, reduces food intake, inhibits glucagon secretion)
give type/mechanism: linagliptin
DPP-4 inhibitor
increase insulin
decrease glucagon release
DPP-4 enzyme inactives GLP-1
give type/mechanism: saxagliptin
DPP-4 inhibitor
increase insulin
decrease glucagon release
DPP-4 enzyme inactives GLP-1
give type/mechanism: sitagliptin
DPP-4 inhibitor
increase insulin
decrease glucagon release
DPP-4 enzyme inactives GLP-1
contraindication of Metformin
can cause lactic acidosis, so contraindicated for anyone predisposed to that: heart failure, liver disease, severe hypoxia, renal insufficiency